101
Views
2
CrossRef citations to date
0
Altmetric
Commentary on selected article in this issue

Do lymphocytes count in myeloma? Are we absolutely sure?

References

  • Shapiro-Shelef M, Calame K. Plasma cell differentiation and multiple myeloma. Curr Opin Immunol 2004;16:226–234.
  • Sewell RL. Lymphocyte abnormalities in myeloma. Br J Haematol 1977;36:545–551.
  • Twomey JJ, Laughter AH, Rice L, et al. Suppression of lymphocyte responses by monocytes with untreated and treated multiple myeloma. Blood 1982;60:316–322.
  • Pilarski LM, Mant MJ, Ruether BA, et al. Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients. J Clin Invest 1984;74:1301–1306.
  • Rawstron AC, Davies FE, Owen RG, et al. B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors. Br J Haematol 1998;100:176–183.
  • Bari A, Tadmor T, Sacchi S, et al. Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy. Br J Haematol 2014;167:133–136.
  • Porrata LF, Ristow K, Colgan JP, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica 2012;97:262–269.
  • Ege H, Gertz MA, Markovic SN, et al. Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study. Br J Haematol 2008; 141:792–798.
  • Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998;339:1506–1514.
  • Tadmor T, Polliack A. Lymphopenia a simple prognostic factor in lymphoma and other cancers: why not use it more as a guide? Leuk Lymphoma 2010;51:1773–1774.
  • Shin SJ, Roh J, Kim M, et al. Prognostic significance of absolute lymphocyte count/absolute monocyte count ratio at diagnosis in patients with multiple myeloma. Korean J Pathol 2013; 47:526–533.
  • Song MK, Chung JS, Joo YD, et al. Clinical value of absolute lymphocyte counts before bortezomib-dexamethasone therapy in relapsed multiple myeloma patients. Acta Haematol 2010;124:34–39.
  • Napolitano M, Saccullo G, Bono R, et al. Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory drugs. Leuk Lymphoma 2015;56:1507–1509.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.